Acute myeloid leukemia (AML), also known as acute myelocytic leukemia, acute myelogenous leukemia, acute granulocytic leukemia, and acute non-lymphocytic leukemia is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. AML can involve tissues outside the bone marrow and blood, including lymph nodes, the brain, skin, and other parts of the body.
DelveInsight has added a new research study on Acute Myeloid Leukemia Market Report with detailed information on the overview, market insights, drugs industry, treatment, growth, size, share, trends, during the forecast period of 2017 to 2030
Some key facts of Acute Myeloid Leukemia Market Report:
Request Sample Report @ https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-market
Acute Myeloid Leukemia Market Report Highlights
List of Key Players involved in the Acute myeloid leukemia Market report
Acute Myeloid Leukemia Therapies are:
· ASTX 727
· CPI-613
· CX-01
· APL-106
· Quizartinib
· MLN-4924
· Iomab-B
· SLS-001
· ARO-002
· MGD-006
· FT-2102
· DF9-10917
· SNDX-5613
· And Many More
Table of Content
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Business Consulting Services with a credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-market